loading page

Case report: strong lung reaction to the BNT162b2 mRNA vaccine applied one month after a pulmonary form of covid-19
  • Alejandra Aguilar Robles,
  • YVES CARLIER
Alejandra Aguilar Robles
Hospital Regional Tlalnepantla (ISSEMYN)
Author Profile
YVES CARLIER
ULB Université Libre de Bruxelles

Corresponding Author:ycarlier@ulb.ac.be

Author Profile

Abstract

This case report documents a reactivation of a pulmonary pathology, beginning some hours after the administration of a first dose of BNT162b2 mRNA vaccine, in a patient having presented a symptomatic pulmonary form of covid-19 one month before. The lessons to be learned and the possible involved mechanisms are discussed.